To all our Supporters, Friends and Colleagues and especially to the Patients and Caregivers we serve and to the Healthcare Workers who tirelessly work on behalf of all of us!
First of all, I want to take this opportunity to mark the passing of a momentous year and wish everyone a much better 2021. It certainly has been quite the ride!
I want to start off 2021 by sharing exciting news from Corporate Partner GT Medical who offer a truly groundbreaking treatment for those undergoing surgery for their brain tumor in the form of safe and effective surgically targeted radiation delivered right to the tumor site.
I personally believe that GammaTile Therapy is a game changer for patients with malignant brain tumors and would like to personally congratulate those centers achieving ELITE status in 2020:
- Memorial Sloan Kettering Cancer Center
- University of Minnesota M Health Fairview
- HonorHealth Scottsdale Osborn Medical Center
- NorthShore University HealthSystem
- Mayfield Brain & Spine
Read the full press release HERE.
I am looking for these numbers to increase exponentially in 2021. Because it means that far more patients with brain tumors will start off their journey with radiation that’s targeted to their tumor and is much less debilitating. This represents a double win and I can’t wait for the day when GammaTile Therapy becomes standard practice.
Happy New Year and cheers!
Dellann Elliott Mydland
President & CEO
EndBrainCancer Initiative (EBCI)/Chris Elliott Fund
“There is currently no other device that is able to achieve what GammaTile has for our brain tumor patients. It is the first device of its kind, and its ability to deliver safe and effective surgically targeted radiation is groundbreaking in the neuro-oncology community. We’re proud to be included in this year’s group of GammaTile Therapy ELITE Member institutions.”
-Dr. Julian Bailes
Chair of the Department of Neurosurgery, NorthShore University Health System
